Ilaria Fregno

Any wrong or incomplete data? Any missing, misplaced, unlicensed picture? Please report any abuse, inaccuracy or lack of information to info@ticinoscienza.ch

1) ER-to-lysosome-associated degradation acts as failsafe mechanism upon ERAD dysfunction

EMBO reports, giugno 2024

2) Validation of a highly sensitive HaloTag-based assay to evaluate the potency of a novel class of allosteric beta-Galactosidase correctors

PloS One, 29 novembre 2023

3) N-glycan processing selects ERAD-resistant misfolded proteins for ER-to-lysosome-associated degradation

The Embo Journal, 21 giugno 2021

Facts & figures

Ilaria Fregno has coordinated or participated in 3 publications
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) whose subjects can be represented by this 11 elements tag cloud:

ER-phagy (4) protein quality control (4) endoplasmic reticulum (ER) (2) ER-associated Degradation (ERAD) (2) ER-to-Lysosome-associated Degradation (ERLAD) (2) ERAD (2) ERLAD (2) N-glycan processing (2) Site-directed Enzyme Enhancement Therapy (SEE-Tx®) (1) structurally targeted allosteric regulators (STARs) (1) β-Galactosidase (1)

Ilaria Fregno has coordinated or participated in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) featured by 3 scientific journals:

EMBO reports (2) PLoS One (2) The Embo Journal (2)

Ilaria Fregno has coordinated or participated in 3 publications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) involving also 8 co-authors being active in Ticino:

Maurizio Molinari (6) Tatiana Soldà (6) Carmela Galli (4) Elisa Fasana (4) Timothy Jan Bergmann (2) Manolo Bellotto (2) Mikhail Rudinkiy (1) Mikhail Rudinskiy (1)

Ilaria Fregno has coordinated or participated in 3 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations) in whose synopsis the 17 most frequently used terms (excluding 15 not relevant terms) are here listed:

I.F. WORD CLOUD er-to-lysosome-associated (2) degradation (2) n-glycan (1) selects (1) erad-resistant (1) misfolded (1) proteins (1) sensitive (1) halotag-based (1) assay (1) allosteric (1) beta-galactosidase (1) correctors (1) acts (1) failsafe (1) upon (1) erad (1)

In the synopsis of the whole 3332 pubblications (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations), the 197 most frequently used terms (excluding 15 not relevant or unfrequently used terms (terms used less than 10 times) are here listed:

THE WHOLE WORD CLOUD cancer (299) covid- (186) thyroid (111) pet (109) cardiac (107) prostate (107) sars-cov- (103) hiv (89) atrial (81) breast (81) coronary (79) sclerosis (76) fibrillation (69) lymphoma (68) pandemic (67) bone (54) aortic (52) heart (51) artery (51) stroke (50) liver (47) carcinoma (46) brain (44) antibodies (42) cardiovascular (41) lung (40) mri (39) transcatheter (36) metastatic (35) dna (35) ventricular (35) kidney (34) nodules (34) tumor (33) extracellular (33) virus (33) myocardial (32) knee (31) ultrasound (30) oncology (30) mitral (27) antibody (27) esmo (27) percutaneous (26) f-fdg (26) hepatitis (25) vesicles (25) spinal (25) antiplatelet (24) cervical (24) ischemic (24) osteoarthritis (23) tuberculosis (23) diabetes (23) infarction (23) chemotherapy (23) ovarian (22) sentinel (22) radiotherapy (22) bladder (22) pulmonary (22) sperm (22) ehra (22) endovascular (21) implantation (21) transplantation (21) vaccination (21) renal (21) blood (20) lymph (19) resonance (19) plasma (19) tomography (19) urinary (19) bacterial (19) b-cell (18) monoclonal (18) nuclear (18) tumors (18) pacing (18) fdg (17) colorectal (17) laparoscopic (17) mice (17) implantable (16) autoimmune (16) vaccine (16) transplant (16) coronavirus (16) immunodeficiency (16) radiomics (15) membrane (15) preclinical (15) metabolic (15) metabolism (15) vascular (15) musculoskeletal (15) tricuspid (14) endometrial (14) pneumonia (14) antiretroviral (14) biomarker (14) serum (14) mrna (14) metastasis (14) lymphomas (14) fractures (14) peripheral (14) neurocognitive (14) leukemia (14) occlusion (13) male (13) behavior (13) muscle (13) interventions (13) legs (13) radiation (13) arterial (13) hemorrhage (13) nerve (13) biomarkers (13) pregnancy (13) lymphocytic (13) medullary (12) malignant (12) platelet-rich (12) hiv- (12) metastases (12) tau (12) iga (12) conference (12) mutations (12) malignancy (12) brugada (12) joint (12) fna (12) grafts (12) ischemia (12) dementia (12) esc (12) radiology (11) baseline (11) gastric (11) intravenous (11) arrhythmia (11) dynamic (11) incontinence (11) burden (11) pi (11) contemporary (11) contrast-enhanced (11) pathways (11) adherence (11) catheter (11) parkinson (11) limb (11) cytology (11) signaling (11) neck (11) mesenchymal (11) senescence (11) lockdown (11) il- (11) administration (10) overview (10) regurgitation (10) depression (10) art (10) idiopathic (10) clonal (10) bayesian (10) checkpoint (10) antithrombotic (10) precision (10) recovery (10) possible (10) prognosis (10) cancers (10) vascularized (10) adapted (10) peptide (10) ecg (10) infectious (10) fixation (10) prolapse (10) pci (10) hip (10) migraine (10) skin (10) prophylaxis (10) follicular (10) igg (10) vitamin (10) epidemiology (10) lipid (10) refractory (10) anesthesia (10)

Ilaria Fregno has coordinated or participated in the 3 publications here listed (as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations)

1) ER-to-lysosome-associated degradation acts as failsafe mechanism upon ERAD dysfunction

2) Validation of a highly sensitive HaloTag-based assay to evaluate the potency of a novel class of allosteric beta-Galactosidase correctors

3) N-glycan processing selects ERAD-resistant misfolded proteins for ER-to-lysosome-associated degradation

Ilaria Fregno has coordinated or participated in the 3 publications here listed
(as cross-checked throughout PubMed, counted from 2020, including only Ticino affiliations)